Jeffrey M. Isner

Q: What Schools Are Affiliated With Jeffrey M. Isner

Jeffrey M. Isner is affiliated with the following schools: Yale University, Tufts University, Tokai University, Duke University

Jeffrey M. Isner's AcademicInfluence.com Rankings

Jeffrey M. Isner

Philosophy

#3388

World Rank

#5492

Historical Rank

Logic

#1126

World Rank

#1789

Historical Rank

philosophy Degrees

Jeffrey M. Isner

Biology

#4227

World Rank

#6336

Historical Rank

Molecular Biology

#312

World Rank

#317

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Jeffrey M. Isner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jeffrey M. Isner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Isolation of Putative Progenitor Endothelial Cells for Angiogenesis (1997) (8778)
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. (1999) (3421)
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization (1999) (2553)
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. (2000) (2042)
VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells (1999) (1945)
Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia (2001) (1297)
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. (1998) (1241)
Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization (2003) (1208)
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. (1998) (1114)
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. (1994) (1064)
Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. (1998) (1022)
Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells (2002) (998)
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb (1996) (984)
Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. (1999) (791)
Age-dependent impairment of angiogenesis. (1999) (760)
HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. (2001) (734)
Mouse model of angiogenesis. (1998) (730)
Apoptosis in human atherosclerosis and restenosis. (1995) (720)
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. (1998) (704)
Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia (2003) (691)
Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. (1979) (674)
The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors (2001) (650)
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. (1995) (622)
Endothelial Progenitor Cell Vascular Endothelial Growth Factor Gene Transfer for Vascular Regeneration (2002) (619)
Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. (2000) (619)
Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. (1995) (572)
Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. (1995) (544)
Acute cardiac events temporally related to cocaine abuse. (1986) (534)
Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. (1994) (527)
Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells (*) (1995) (506)
Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. (1998) (505)
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. (1999) (492)
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. (1998) (468)
Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial Ischemia (2002) (463)
Chemotactic Properties of Angiopoietin-1 and -2, Ligands for the Endothelial-specific Receptor Tyrosine Kinase Tie2* (1998) (450)
Right ventricular infarction complicating left ventricular infarction secondary to coronary heart disease. Frequency, location, associated findings and significance from analysis of 236 necropsy patients with acute or healed myocardial infarction. (1978) (440)
Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury (2003) (439)
Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. (1997) (420)
Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. (1996) (412)
Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. (1992) (395)
Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. (1998) (389)
Myocardial gene therapy (2002) (377)
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity (1997) (373)
Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. (1998) (365)
Indirect Angiogenic Cytokines Upregulate VEGF and bFGF Gene Expression in Vascular Smooth Muscle Cells, Whereas Hypoxia Upregulates VEGF Expression Only (1994) (365)
Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. (1996) (362)
Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. (1999) (344)
Angiogenesis Is Induced in a Rabbit Model of Hindlimb Ischemia by Naked DNA Encoding an HIF-1&agr;/VP16 Hybrid Transcription Factor (2000) (331)
Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. (2001) (330)
Role of endothelial nitric oxide synthase in endothelial cell migration. (1999) (327)
Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial Ischemia (2000) (325)
Estrogen and Angiogenesis: A Review (2001) (317)
Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. (2000) (316)
Constitutive Human Telomerase Reverse Transcriptase Expression Enhances Regenerative Properties of Endothelial Progenitor Cells (2002) (313)
Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. (1994) (310)
Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. (1997) (303)
Progressive Attenuation of Myocardial Vascular Endothelial Growth Factor Expression Is a Seminal Event in Diabetic Cardiomyopathy: Restoration of Microvascular Homeostasis and Recovery of Cardiac Function in Diabetic Cardiomyopathy After Replenishment of Local Vascular Endothelial Growth Factor (2005) (301)
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity* (2000) (298)
VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. (2000) (296)
Accuracy of Angiographic Determination of Left Main Coronary Arterial Narrowing: Angiographic‐Histologic Correlative Analysis in 28 Patients (1981) (296)
Reversal of experimental diabetic neuropathy by VEGF gene transfer. (2001) (288)
Histopathology of in-stent restenosis in patients with peripheral artery disease. (1997) (284)
Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation. (2000) (284)
Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. (1999) (277)
Randomized, Single-Blind, Placebo-Controlled Pilot Study of Catheter-Based Myocardial Gene Transfer for Therapeutic Angiogenesis Using Left Ventricular Electromechanical Mapping in Patients With Chronic Myocardial Ischemia (2001) (275)
VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. (1996) (274)
Anorexia nervosa and sudden death. (1985) (271)
Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. (1997) (267)
Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. (1996) (265)
Ultrasound angioscopy: real-time, two-dimensional, intraluminal ultrasound imaging of blood vessels. (1988) (254)
Correlation of B-mode ultrasound imaging and arteriography with pathologic findings at carotid endarterectomy. (1985) (251)
Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. (1987) (250)
Estradiol accelerates functional endothelial recovery after arterial injury. (1997) (249)
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. (2003) (248)
Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy (2000) (243)
Focal compensatory enlargement of human arteries in response to progressive atherosclerosis. In vivo documentation using intravascular ultrasound. (1994) (243)
Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. (1994) (242)
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. (1996) (230)
Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. (1995) (229)
Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. (1997) (229)
The biology of restenosis. (1997) (225)
Three-Dimensional Reconstruction of Human Coronary and Peripheral Arteries From Images Recorded During Two-Dimensional Intravascular Ultrasound Examination (1991) (218)
Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents: An Alternative Strategy for Inhibition of Restenosis (2004) (218)
Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. (1997) (218)
Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. (1994) (216)
Therapeutic Angiogenesis for Coronary Artery Disease (2002) (216)
Postnatal Recapitulation of Embryonic Hedgehog Pathway in Response to Skeletal Muscle Ischemia (2003) (212)
Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. (2001) (210)
Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. (1997) (207)
Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. (1995) (204)
Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval. (1979) (200)
Lower-Extremity Edema Associated with Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor (2000) (199)
The excimer laser: gross, light microscopic and ultrastructural analysis of potential advantages for use in laser therapy of cardiovascular disease. (1985) (198)
Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. (1998) (197)
Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. (1993) (194)
Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. (1999) (191)
Therapeutic angiogenesis for ischemic cardiovascular disease. (2001) (187)
Cystic medial necrosis in coarctation of the aorta: a potential factor contributing to adverse consequences observed after percutaneous balloon angioplasty of coarctation sites. (1987) (186)
Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. (1996) (185)
Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia Clinical Investigation and Reports (1998) (183)
In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. (1993) (179)
Multicenter trial of the wallstent in the iliac and femoral arteries. (1995) (173)
Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. (1997) (168)
Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. (1996) (168)
Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. (1996) (168)
Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. (1994) (160)
Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. (1999) (160)
How Does Angioplasy Work?: Serial Analysis of Human Iliac Arteries Using Intravascular Ultrasound (1992) (159)
Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. (1997) (153)
Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. (1995) (151)
Assessment of risks associated with cardiovascular gene therapy in human subjects. (2001) (150)
Reversible cardiomyopathy associated with cocaine intoxication. (1989) (146)
Endothelial progenitor cells for vascular regeneration. (2002) (145)
Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. (1993) (144)
Our national obsession with potassium. (1982) (141)
Redefining the Treatment of Peripheral Artery Disease Role of Percutaneous Revascularization (1993) (134)
Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. (1992) (133)
Therapeutic angiogenesis for heart failure (1999) (127)
Cocaine and vasospasm. (1989) (126)
Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. (2001) (126)
Prospects for site-specific delivery of pharmacologic and molecular therapies. (1994) (125)
Attenuation of the media of coronary arteries in advanced atherosclerosis. (1986) (125)
Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy. (1993) (125)
Coronary artery perforation during excimer laser coronary angioplasty. The percutaneous Excimer Laser Coronary Angioplasty Registry. (1993) (124)
Complications of the intraaortic balloon counterpulsation device: clinical and morphologic observations in 45 necropsy patients. (1980) (124)
Reduction of laser-induced pathologic tissue injury using pulsed energy delivery. (1985) (124)
Targeting Kinin B1 Receptor for Therapeutic Neovascularization (2002) (123)
Sudden death in Prinzmetal's angina with coronary spasm documented by angiography. Analysis of three necropsy patients. (1982) (122)
Factors influencing immediate results, complications, and short-term follow-up status after Inoue balloon mitral valvotomy: a North American multicenter study. (1992) (121)
Long-term clinical course of patients with normal coronary arteriography: follow-up study of 121 patients with normal or nearly normal coronary arteriograms. (1981) (120)
Percutaneous intravascular US as adjunct to catheter-based interventions: preliminary experience in patients with peripheral vascular disease. (1990) (120)
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. (2003) (120)
Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. (1995) (117)
One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I) (1995) (114)
Treatment of calcific aortic stenosis by balloon valvuloplasty. (1987) (114)
Combination Balloon‐Ultrasound Imaging Catheter for Percutaneous Transluminal Angioplasty: Validation of Imaging, Analysis of Recoil, and Identification of Plaque Fracture (1991) (113)
Gene therapy for myocardial angiogenesis. (1999) (111)
Restenosis of endovascular stents from stent compression. (1997) (111)
Overexpression of p27Kip1 by doxycycline‐regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis (2001) (111)
Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients studied at necropsy. (1983) (110)
Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. (1999) (110)
Vascular remodeling. Honey, I think I shrunk the artery. (1994) (109)
Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. (1994) (108)
Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries. (1998) (103)
Histochemical staining following LacZ gene transfer underestimates transfection efficiency. (1997) (103)
Use of pulsed energy delivery to minimize tissue injury resulting from carbon dioxide laser irradiation of cardiovascular tissues. (1986) (102)
Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. (1997) (101)
Effect of Valve Deformity on Results and Mitral Regurgitation After Inoue Balloon Commissurotomy (1992) (100)
Expression of gax, a Growth Arrest Homeobox Gene, Is Rapidly Down-regulated in the Rat Carotid Artery during the Proliferative Response to Balloon Injury (*) (1995) (99)
Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse (1994) (99)
Use of the Rabbit Ear Artery to Serially Assess Foreign Protein Secretion After Site‐Specific Arterial Gene Transfer In Vivo: Evidence That Anatomic Identification of Successful Gene Transfer May Underestimate the Potential Magnitude of Transgene Expression (1994) (97)
Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. (1999) (97)
Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. (1997) (97)
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication (2001) (95)
Bone Marrow as a Source of Endothelial Cells for Natural and Iatrogenic Vascular Repair (2001) (93)
Endothelial recovery: the next target in restenosis prevention. (2003) (91)
Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA. (1997) (90)
Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation. (1997) (90)
Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. (1997) (89)
Mechanisms and outcome of severe mitral regulation after inoue balloon valvuloplasty (1993) (85)
Direct myocardial transfection in two animal models. Evaluation of parameters affecting gene expression and percutaneous gene delivery. (1993) (84)
COMPUTED TOMOGRAPHY IN THE DIAGNOSIS OF PERICARDIAL HEART DISEASE (1982) (83)
Cancer and atherosclerosis: the broad mandate of angiogenesis. (1999) (83)
In vitro analysis of mechanisms of balloon valvuloplasty of stenotic mitral valves. (1987) (83)
Inoue balloon mitral valvotomy in patients with severe valvular and subvalvular deformity. (1995) (82)
Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle. (2000) (81)
Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients. (2005) (80)
Sudden unexpected death as a result of anomalous origin of the right coronary artery from the left sinus of Valsalva. (1984) (78)
Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy. (1980) (78)
Smooth muscle cell outgrowth from human atherosclerotic plaque: implications for the assessment of lesion biology. (1992) (78)
Evidence Implicating Nonmuscle Myosin in Restenosis: Use of In Situ Hybridization to Analyze Human Vascular Lesions Obtained by Directional Atherectomy (1992) (77)
Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF. (2007) (77)
Lipomatous hypertrophy of the interatrial septum: in vivo diagnosis. (1982) (75)
Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart failure. (1985) (75)
Real-time intravascular ultrasound imaging in humans. (1990) (72)
Lack of effect of aspirin on myocardial infarct size in the dog. (1981) (72)
Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia. (2003) (72)
Factors contributing to perforations resulting from laser coronary angioplasty: observations in an intact human postmortem preparation of intraoperative laser coronary angioplasty. (1985) (72)
Endothelial regrowth after arterial injury: from vascular repair to therapeutics. (1998) (70)
Liposome-mediated gene transfer into human vascular smooth muscle cells. (1994) (70)
Transcutaneous ultrasound augments naked DNA transfection of skeletal muscle. (2002) (70)
Antiangiogenesis Mediates Cisplatin-Induced Peripheral Neuropathy: Attenuation or Reversal by Local Vascular Endothelial Growth Factor Gene Therapy Without Augmenting Tumor Growth (2005) (70)
Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry. (1994) (69)
Divergence of Angiogenic and Vascular Permeability Signaling by VEGF: Inhibition of Protein Kinase C Suppresses VEGF-Induced Angiogenesis, but Promotes VEGF-Induced, NO-Dependent Vascular Permeability (2002) (69)
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. (1994) (68)
Recommendations for peripheral transluminal angioplasty: training and facilities. American College of Cardiology Peripheral Vascular Disease Committee. (1993) (66)
Identification of photoproducts liberated by in vitro argon laser irradiation of atherosclerotic plaque, calcified cardiac valves and myocardium. (1985) (65)
Therapeutic angiogenesis in critical limb and myocardial ischemia. (2001) (63)
Gene Therapy with Vascular Endothelial Growth Factor for Inoperable Coronary Artery Disease: Anesthetic Management and Results (2001) (62)
Cardiovascular complications of cocaine. (1991) (62)
Spectroscopic characterization of cardiovascular tissue (1988) (62)
Atherosclerotic Yucatan microswine: an animal model with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions. (1990) (61)
Theory of photoablation and its implications for laser phototherapy (1985) (60)
Current status of cardiovascular laser therapy, 1987 (1987) (60)
Obstruction of right ventricular outflow tract caused by intracavitary metastatic disease: analysis of 14 cases. (1992) (59)
Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis. (1992) (57)
Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial (1998) (57)
VEGF gene transfer for diabetic neuropathy. (2001) (56)
Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor. (1998) (56)
Percutaneous Delivery of Low‐Level Laser Energy Reverses Histamine‐Induced Spasm in Atherosclerotic Yucatan Microswine (1992) (56)
Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure (1986) (55)
Functional Ephrin-B2 Expression for Promotive Interaction Between Arterial and Venous Vessels in Postnatal Neovascularization (2005) (54)
Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes. (1993) (53)
Therapeutic Angiogenesis: A New Frontier for Vascular Therapy (1996) (53)
The current status of lasers in the treatment of cardiovascular disease (1984) (53)
Arterial Gene Therapy for Restenosis. St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts (1996) (52)
A new balloon-expandable tantalum coil stent: angiographic patency and histologic findings in an atherogenic swine model. (1992) (51)
Acute catastrophic complications of balloon aortic valvuloplasty (1991) (51)
Chronic ischemic monomelic neuropathy from critical limb ischemia (2001) (50)
Vasodilator effect on right ventricular function in congestive heart failure and pulmonary hypertension: end-systolic pressure--volume relation. (1984) (50)
Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication (2001) (49)
Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries (2000) (49)
Somatic gene therapy in the cardiovascular system. (2001) (48)
A proliferation analysis of arterial neointimal hyperplasia: lessons for antiproliferative restenosis therapies. (1996) (47)
Time course of recombinant protein secretion after liposome-mediated gene transfer in a rabbit arterial organ culture model. (1994) (47)
Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-alpha-induced apoptosis. (1998) (47)
Length of hospital stay and complications after percutaneous transluminal coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators. (1995) (47)
Prevention of smooth muscle cell outgrowth from human atherosclerotic plaque by a recombinant cytotoxin specific for the epidermal growth factor receptor. (1993) (47)
Gas chromatographic-light microscopic correlative analysis of excimer laser photoablation of cardiovascular tissues: evidence for a thermal mechanism. (1987) (46)
Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF). (1998) (45)
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. (2001) (45)
Oncogenic ras induces premature senescence in endothelial cells: role of p21Cip1/Waf1 (2002) (45)
Disseminated Petriellidium boydii and pacemaker endocarditis. (1980) (43)
Differentiation of constrictive pericarditis from restrictive cardiomyopathy by computed tomographic imaging (1983) (43)
Intraoperative multiplane transesophageal echocardiography for guiding direct myocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectoris. (1999) (42)
Contrasting histoarchitecture of calcified leaflets from stenotic bicuspid versus stenotic tricuspid aortic valves. (1990) (42)
Cardiac findings in Charcot-Marie-Tooth disease. A prospective study of 68 patients. (1979) (41)
Right ventricular myocardial infarction. (1988) (41)
Gene therapy for the vulnerable plaque. (1995) (41)
In Vivo Assessment of Vascular Pathology Resulting From Laser Irradiation: Analysis of 23 Patients Studied by Directional Atherectomy Immediately After Laser Angioplasty (1992) (41)
Pulsed ultraviolet laser irradiation produces endothelium-independent relaxation of vascular smooth muscle. (1989) (40)
Combined physiologic and anatomic assessment of percutaneous revascularization using a Doppler guidewire and ultrasound catheter. (1993) (40)
Critical Limb Ischemia: Nothing To Give at the Office? (1999) (40)
Gene therapy for arterial disease (1994) (39)
Failure of angiography to accurately depict the extent of coronary artery narrowing in three fatal cases of percutaneous transluminal coronary angioplasty. (1992) (38)
Effect of argon laser irradiation on rabbit aortic smooth muscle: evidence for endothelium independent contraction and relaxation. (1988) (38)
Laser myoplasty for hypertrophic cardiomyopathy. In vitro experience in human postmortem hearts and in vivo experience in a canine model (transarterial) and human patient (intraoperative). (1984) (37)
Frequency in nonangioplasty patients of morphologic findings reported in coronary arteries treated with transluminal angioplasty. (1983) (37)
Laser angioplasty: unraveling the Gordian knot. (1986) (37)
Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA. (2002) (36)
Gene therapy for peripheral vascular disease. (2000) (36)
Laser Raman spectroscopy of calcified atherosclerotic lesions in cardiovascular tissue. (1987) (36)
Cardiac complications of cocaine abuse. (1991) (36)
Epidermal growth factor receptor-targeted cytotoxin inhibits neointimal hyperplasia in vivo. Results of local versus systemic administration. (1995) (36)
Mechanisms and outcome of severe mitral regurgitation after Inoue balloon valvuloplasty. North American Inoue Balloon Investigators. (1993) (35)
The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation. (1996) (35)
Mechanism of aortic balloon valvuloplasty: fracture of valvular calcific deposits. (1988) (35)
Differential expression of 92-kDa gelatinase in primary atherosclerotic versus restenotic coronary lesions. (1997) (33)
Laser-induced dissections: pathogenesis and implications for therapy. (1992) (33)
Percutaneous Myocardial Gene Transfer of phVEGF-2 (1999) (33)
Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis. (1998) (33)
Cardiovascular laser therapy (1989) (32)
Coronary angiographic and morphologic correlation. (1984) (32)
Human coronary and peripheral arteries: on-line three-dimensional reconstruction from two-dimensional intravascular US scans. Work in progress. (1992) (31)
Directional coronary atherectomy in heart transplant recipients. (1993) (31)
Treatment of cardiogenic shock by emergency aortic balloon valvuloplasty. (1988) (31)
Manipulating angiogenesis against vascular disease. (1999) (30)
Subepicardial adipose tissue producing echocardiographic appearance of pericardial effusion. Documentation by computed tomography and necropsy. (1983) (30)
Elevated levels of basic fibroblast growth factor in patients with limb ischemia. (1996) (30)
The relation of clinical outcome to dissection and thrombus formation during coronary angioplasty. Heparin Registry Investigators. (1995) (30)
[Angiogenesis and vasculogenesis. Therapeutic strategies for stimulation of postnatal neovascularization]. (2000) (30)
Still more debate over VEGF (2001) (29)
Pseudoischemic "false positive" S-T segment changes induced by hyperventilation in patients with mitral valve prolapse. (1980) (29)
Arterial gene therapy for restenosis. (1996) (29)
Processing of chimeric antisense oligonucleotides by human vascular smooth muscle cells and human atherosclerotic plaque. Implications for antisense therapy of restenosis after angioplasty. (1996) (29)
The role of angiogenic cytokines in cardiovascular disease. (1996) (28)
Real-time three-dimensional reconstruction of intravascular ultrasound images of iliac arteries. (1992) (28)
Mechanism of laser ablation in an absorbing fluid field (1988) (28)
Excimer laser coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experience. (1997) (28)
Comparison of the electrocardiographic and hemodynamic responses to ionic and nonionic radiocontrast media during left ventriculography: a randomized double-blind study. (1986) (27)
Clinical and noninvasive hemodynamic results after aortic balloon valvuloplasty for aortic stenosis. (1988) (27)
Combined posteroanterior subepicardial fat simulating the echocardiographic diagnosis of pericardial effusion. (1984) (27)
Excimer laser atherectomy. The greening of Sisyphus. (1990) (27)
Angiogenesis for revascularization of ischaemic tissues. (1997) (27)
Comparison of histamine release effects of ionic and non-ionic radiographic contrast media. (1986) (26)
Right ventricular infarction with hemodynamic decompensation due to transient loss of active atrial augmentation: successful treatment with atrial pacing. (1981) (25)
Effect of balloon size and stepwise inflation technique on the acute results of Inoue mitral commissurotomy. Inoue Balloon Catheter Investigators. (1993) (25)
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia (2005) (24)
Intercoronary continuity: an anatomic basis for bidirectional coronary blood flow distinct from coronary collaterals. (1984) (24)
HLA antigens in mitral valve prolapse. (1977) (24)
Left ventricular incision midway between the mitral anulus and the stumps of the papillary muscles during mitral valve excision with or without rupture or aneurysmal formation: analysis of 10 necropsy patients. (1982) (24)
Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb? (2001) (23)
Aortic insufficiency requiring valve replacement in Whipple's disease. (1978) (23)
Three-dimensional reconstruction of human carotid arteries from images obtained during noninvasive B-mode ultrasound examination. (1992) (23)
Heterotopic heart transplantation: electrophysiologic changes during acute rejection. (1988) (23)
Engineering the Response to Vascular Injury Divergent Effects of Deregulated E2F1 Expression on Vascular Smooth Muscle Cells and Endothelial Cells Result in Endothelial Recovery and Inhibition of Neointimal Growth (2003) (22)
Comparison of amount of myocardial cell disorganization in operatively excised septectomy specimens with amount observed at necropsy in 18 patients with hypertrophic cardiomyopathy. (1980) (22)
Catheter-based intravascular ultrasound discriminates bicuspid from tricuspid valves in adults with calcific aortic stenosis. (1990) (22)
Management of cardiac disease in the general surgical patient. (1980) (21)
Cardiac sarcoma causing "ASH" and simulating coronary heart disease. (1979) (21)
Laser photoablation of pathological endocardium: in vitro findings suggesting a new approach to the surgical treatment of refractory arrhythmias and restrictive cardiomyopathy. (1985) (21)
Acute catastrophic complications of balloon aortic valvuloplasty. The Mansfield Scientific Aortic Valvuloplasty Registry Investigators. (1991) (21)
Laser Raman spectroscopy of atherosclerotic lesions in human coronary artery segments. (1988) (21)
Possible myocardial toxicity associated with interleukin-4 therapy. (1993) (21)
Catheter-induced versus spontaneous spasm. Do these coronary bedfellows deserve to be estranged? (1985) (21)
Laser-assisted debridement of aortic valve calcium. (1985) (20)
Persistently increased expression of the transforming growth factor-β1 gene in human vascular restenosis: Analysis of 62 patients with one or more episode of restenosis. (1994) (20)
Hypertrophic cardiomyopathy, myocarditis, and other myopericardial diseases and mitral valve prolapse (1994) (20)
Percutaneous balloon valvuloplasty of mitral stenosis aided by cardiac ultrasound. (1987) (20)
Vascular endothelial growth factor-induced angiogenesis: crouching tiger or hidden dragon? (2001) (19)
Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb model (2006) (19)
Vascular spasm complicates continuous wave but not pulsed laser irradiation. (1989) (19)
Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. (1987) (19)
Dual balloon technique for valvuloplasty of aortic stenosis in adults. (1988) (18)
Differential expression of nonmuscle myosin II isoforms in human atherosclerotic plaque. (1997) (18)
Cardiovascular consequences of recombinant DNA technology: interleukin-2. (1988) (18)
Noninvasive assessment of peripheral vascular disease by color flow Doppler/two-dimensional ultrasound. (1989) (17)
Limitations of color flow Doppler imaging in the quantification of valvular regurgitation: velocity of regurgitant jet, rather than volume, determines size of color Doppler image. (1993) (17)
Vascular smooth muscle cell growth arrest on blockade of thrombospondin-1 requires p21Cip1/WAF1. (1999) (17)
Ultrasound Angioscopy: Feasibility and Potential (1989) (17)
Differentiation of constrictive pericarditis from restrictive cardiomyopathy by computed tomographic imaging. (1984) (16)
Inteavascular ultrasound assessment of implanted endovascular stents (1990) (15)
Pathology of mitral commissurotomy performed with the Inoue catheter: implications for mechanisms and complications. (1994) (15)
Detection of calcific deposits in atherosclerotic lesions by laser Raman spectroscopy (1988) (15)
[Vascular endothelial factor (VEGF): therapeutic angiogenesis and vasculogenesis in the treatment of cardiovascular disease]. (1999) (14)
Cocaine produces vasoconstriction of human coronary arteries: In vitro studies using coronary arteries obtained from freshly explanted human hearts (1990) (14)
Comparison of results of percutaneous balloon valvuloplasty in patients with mild and moderate mitral stenosis to those with severe mitral stenosis. The North American Inoue Balloon Investigators. (1993) (14)
Angiogenic gene therapy: pre-clinical studies and phase I clinical data. (2002) (13)
Congenital pericardial defect diagnosed by computed tomography. (1985) (13)
Theoretical study of ablative photodecomposition in polymeric solids (1989) (13)
Left and right ventricular myocardial infarction in idiopathic dilated cardiomyopathy (1980) (13)
Recommendations for training in vascular medicine (1993) (13)
Magnetic resonance imaging with gadolinium-DTPA for detecting cardiac transplant rejection in rats. (1988) (13)
Expression of Tie1 and Tie2 Proteins during Reendothelialization in Balloon-Injured Rat Carotid Artery (1999) (12)
Prostaglandin mediation of hemodynamic responses to pulmonary microembolism in rabbits: effects of ibuprofen and meclofenamate. (1987) (12)
The changing profile of patient selection, procedural techniques, and outcomes in excimer laser coronary angioplasty. Participating Investigators of the Percutaneous Excimer Laser Coronary Angioplasty Registry. (1995) (12)
Hemodynamic correlates of left ventricular versus right ventricular radionuclide volumetric responses to vasodilator therapy in congestive heart failure secondary to ischemic or dilated cardiomyopathy. (1987) (12)
The production of short-lived free radicals accompanying laser photoablation of cardiovascular tissue. (1988) (12)
Permanent pacemaker therapy in corrected transposition of the great arteries: analysis of site of lead placement in 40 patients. (1983) (12)
Aortic valvuloplasty: are balloon-dilated valves all they are "cracked" up to be? (1988) (12)
Effect of subintimal resection on initial outcome and restenosis for native coronary lesions and saphenous vein graft disease treated by directional coronary atherectomy. A report from the CAVEAT I and II investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. (1996) (12)
In vivo analysis of intramuscular gene transfer in human subjects studied by on-line ultrasound imaging. (2001) (12)
The persistent enigma of percutaneous angioplasty. (1984) (11)
Calcific pulmonic stenosis in adulthood: treatment by valve replacement (porcine xenograft) with postoperative hemodynamic evaluation. (1979) (11)
Delayed thrombolysis of streptokinase-resistant occlusive thrombus: documentation by pre- and postmortem coronary angiography. (1983) (11)
Atherosclerotic plaque hemorrhage and rupture associated with crescendo claudication. (1992) (11)
Oligonucleotide therapeutics — Novel cardiovascular targets (1997) (11)
Vascular smooth muscle cell growth arrest on blockade of thrombospondin-1 requires p21(Cip1/WAF1). (1999) (10)
Percutaneous aortic valvuloplasty. (1987) (10)
Estrogen and Angiogenesis (2000) (10)
Chlorotetracycline-induced fluorescence from atherosclerotic plaque with uv laser excitation☆ (1987) (9)
Right ventricular infarction complicating left ventricular infarction: A complication exclusively of posterior wall infarction (1978) (9)
Systolic click from a Swan-Ganz catheter: phonoechocardiographic depiction of the underlying mechanism. (1979) (9)
Failure of angiography to diagnose thermal perforation complicating laser angioplasty in a rabbit. (1987) (9)
Angiographic contrast media interference with laser-induced fluorescence excitation and detection in atherosclerotic human coronary arteries. (1991) (9)
Laser‐assisted endocardiectomy for refractory ventricular tachyarrhythmias: preliminaRy intraoperative experience (1987) (9)
[Growth factors for therapeutic angiogenesis in cardiovascular diseases]. (2001) (9)
The paradox of thermal ablation without thermal injury (1987) (9)
Naked cDNA encoding secreted proteins for intra-arterial and intramuscular gene transfer. (1996) (8)
Chronic Myocardial Ischemia Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Phase 1 / 2 Placebo-Controlled , Double-Blind , Dose-Escalating Trial of Myocardial Vascular (2002) (8)
Reduced intimal thickening following alpha(v)beta3 blockade is associated with smooth muscle cell apoptosis. (1998) (8)
Dipyridamole thallium-201 imaging pre- and post-coronary angioplasty for assessment of regional myocardial ischemia in humans. (1989) (8)
Assessment and management of cardiac disease in the surgical patient (1989) (8)
Use of emergency balloon dilation to reverse acute hemodynamic decompensation developing during diagnostic catheterization for aortic stenosis (bailout valvuloplasty). (1989) (8)
Pathology of unstable angina: Analysis of biopsies obtained by directional coronary atherectomy (2005) (8)
Reducing the cardiac risk associated with vascular surgical procedures: balloons as prophylactics. (1992) (8)
Images in Cardiovascular Medicine: Percutaneous myocardial gene transfer of phVEGF-2. (1999) (8)
Percutaneous revascularization in peripheral arterial disease. (1996) (8)
Recommendations for training in vascular medicine. American College of Cardiology Peripheral Vascular Disease Committee. (1993) (8)
Balloon valvuloplasty in adults. (1988) (8)
Percutaneous balloon valvuloplasty: current status (1989) (7)
Angiogenesis and Collateral Formation (1997) (7)
Accelerated re-endothelialization and reduced neointimal thickening following catheter transfer of phVEGF165 (1996) (7)
The Right Ventricle (2011) (7)
Arterial gene therapy: a molecular biological perspective for the treatment of arterial ischemia. (1997) (7)
Assessment of safety and efficiency of intramuscular gene therapy with VEGF-2 in patient with critical limb ischemia (1999) (7)
Enough with the fantastic voyage: will IVUS pay in Peoria? (1992) (7)
Factitious lowering of the serum potassium level after cardiopulmonary resuscitation. Implications for evaluating the arrhythmogenicity of hypokalemia in acute myocardial infarction. (1985) (7)
Atrial septal defect resulting from mitral balloon valvuloplasty: relation of defect morphology to transseptal balloon catheter delivery. (1990) (7)
Time resolved plasma photoemission of myocardium with excimer laser excitation (1988) (7)
COMPARISON OF FREE RADICALS PRODUCED BY LASER AND ULTRASOUND ABLATION OF CARDIOVASCULAR TISSUE (1988) (7)
Endovascular Stents for Iliac Arterial Disease (1993) (7)
Laser therapy in the treatment of cardiovascular disease. (1988) (6)
Assessment of coronary arterial stenoses post-intervention by quantitative angiography versus intracoronary ultrasound in 13 patients undergoing balloon and/or laser coronary angioplasty (1991) (6)
Vascular complications of thorium dioxide. (1978) (6)
Acute myocardial infarction, normal coronary arteries and catheter-induced spasm. (1986) (5)
Cardiac screening for athletes. (1980) (5)
Computed tomographic examination of the heart. (1984) (5)
Editorial comment: Vasa vasorum: Therapeutic implications (1996) (5)
Vasa vasorum: therapeutic implications. (1996) (5)
Current limitations of intravascular ultrasound for quantitative analysis of luminal narrowing (1990) (5)
Vascular applications of human gene therapy. (1995) (5)
Images in cardiovascular medicine. Untreated gangrene in patients with peripheral artery disease. (1994) (5)
3-Dimensional reconstruction of coronary and peripheral vessels from 2-D ivus images: Determination of optimal image acquisition rate during timed pullback (1991) (5)
Donor-specific transfusion and cardiac xenografts. (1988) (5)
Excimer laser angioplasty vs. balloon angioplasty in saphenous vein bypass grafts: quantitative angiographic comparison of matched lesions. (1996) (5)
Inoue balloon mitral valvuloplasty vs. double balloon technique: procedure duration and radiation exposure (1991) (4)
Clinical trials in gene therapy (2000) (4)
Catheter fragmentation: a potential source of catheter embolus. (1983) (4)
Abstract of original contributions: 40th Annual Scientific SessionCombination balloon-ultrasound imaging catheter (BUIC) allows continuous monitoring of balloon inflation, deflation, and immediate recoil in patients undergoing balloon angioplasty (1991) (4)
Cardiac Electrophysiologic Testing: Its Role in the Selection of Antiarrhythmic Drug Regimens for Supraventricular and Ventricular Arrhythmias (1985) (4)
Right ventricular myocardial infarction: clinical aspects (1990) (4)
The cardiologist and the pathologist: the interactions of both and the limitations of each. (1987) (4)
Erratum to “Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA” [Cardiovasc Res 1997;35:470—479] (1998) (4)
Clinical pathologic conference. Left and right ventricular myocardial infarction in idiopathic dilated cardiomyopathy. (1980) (4)
Excimer laser angioplasty: Pygmalion makes it to the ball (1988) (4)
Angiographic patency of a tantalum coil stent (1990) (4)
Endothelial Progenitor Cells (2004) (4)
26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. (1994) (3)
Adverse echocardiographic score does not preclude successful outcome in patients undergoing mitral valvuloplasty with inoue balloon (1991) (3)
Case 46-1983: Myocardial Infarction after Mitral-Valve Replacement (1983) (3)
3-dimensional reconstruction of vascular lumen from images recorded during percutaneous 2-D intravascular ultrasound (1990) (3)
VEGF-induction of angiogenesis (2000) (3)
DIRECT INTRAMYOCARDIAL GENE THERAPY WITH VEGF FOR INOPERABLE CORONARY ARTERY DISEASE: PRELIMINARY CLINICAL RESULTS (1999) (3)
Excimer laser-induced vasoreactivity. (1993) (3)
Intravascular ultrasound (IVUS) for accurate guidance in renal artery stent placement (1996) (3)
Circulatory shock due to ascites and responsive to paracentesis. (1985) (3)
Clinical experience with intravascular ultrasound as adjunct to percutaneous recanalizaticn in 101 consecutive patients (1991) (3)
Angiogenesis: a "breakthrough" technology in cardiovascular medicine. (2000) (3)
Angiogenesis and Gene Therapy (2000) (3)
Magnetic resonance imaging in ischemic injury after heart transplantation in rats. (1991) (3)
Wire-guided excimer laser coronary angioplasty: instrument selection, lesion characterization, and operator technique. (1992) (3)
Revascularization achieved by therapeutic angiogenesis is associated with improvement of tissue perfusion (1996) (3)
The mechanism responsible for laser induced photorelaxation of vascular smooth muscle is limited to uv and visible wavelengths (1989) (3)
Contrasting effects of continuous wave and pulsed laser irradiation on vasoreactivity of atherosclerotic vessels in vitro (1989) (3)
Is doppler ultrasound accurate in screening for restenosis after carotid artery stenting? A comparison with quantitative carotid anglography (2002) (2)
Vascular applications of human gene therapy (2005) (2)
Angiogenesis: Molecular biology, clinical aspects (1996) (2)
Comparison of Effects on Left Ventricular Ejection Fraction of Iopamidol and Renografin During Left Ventriculography and Coronary Arteriography (1984) (2)
Limb loss due to transvenous endocardial pacemaker therapy. (1985) (2)
On-line 3-D reconstruction of 2-D intravascular ultrasound images during balloon angioplasty: Clinical application in patients undergoing percutaneous balloon angioplasty (1991) (2)
3-Dimensional reconstruction of balloon dilated coronary, renal, and femoropopliteal arteries from 2-D intravascular ultrasound images: Analysis of longitudinal sagittal versus cylindrical views (1991) (2)
Vascular smooth muscle cell growth arrest on blockade of thrombospondin-1 requires p 21 Cip 1 / WAF 1 (1999) (2)
[Effect of pulsed excimer laser on arterial smooth muscle]. (1989) (2)
Ultrafast CT in aortic stenosis. (1988) (2)
In situ hybridization of human atherosclerotic material from coronary arteries and saphenous vein graft biopsied with an atherectomy catheter (1991) (2)
Vascular Endothelial Growth Factor in Angiogenesis (1995) (2)
Unique vasomotor response to pulsed Holmium: YAG laser irradiation in vitro (1991) (2)
The anthracycline heart: Analysis of 69 patients treated with either adriamycin or daunorubicin showing a lack of correlation between clinical and morphologic findings (1980) (2)
Therapeutic Angiogenesis (2017) (1)
Abnormal P wave pattern in Reye's syndrome. (1978) (1)
[Cardiac and vascular gene therapy in cardiology. Current status and future prospects]. (2002) (1)
Cocaine-induced myocardial infarction: clinical observations and pathogenetic considerations. (1991) (1)
Supravalvular stenosing ring of the left atrium associated with bilateral atrioventricular valvular regurgitation. (1983) (1)
Quantitative analysis by 3-dimensional intravascular ultrasound. (1992) (1)
Intravascular Ultrasound: Potential for Optimizing Mechanical Solutions to Restenosis (1992) (1)
3-dimensional intravascular ultrasound imaging of human coronary arteries after percutaneous revascularization (1991) (1)
Arterial gene therapy (1996) (1)
Laser myoplasty for hypertrophic cardiomyopathy: Use of a thermocouple to continuously monitor laser-fiber contact with myocardium and for dosimetry (1991) (1)
Are autopsies still useful? Thank goodness we didn't know. Not all tumors are bad tumors. Most of the cavity has to be filled before trouble occurs. (1993) (1)
Pathologic Anatomy of Acquired Ventricular Disease (1985) (1)
Use of inoue balloon catheter to perform staged balloon inflations in combination with serial evaluation by color-flow Doppler minimizes mitral regurgitation as a complication of percutaneous mitral valvuloplasty (1991) (1)
1012-103 Restoration of Endothelial Function in Hypercholesterolemic Rabbit by Intermittent Administration of Vascular Endothelial Growth Factor (1995) (1)
Malignant left main and 3 vessel coronary heart disease in patients undergoing peripheral vascular surgery (1983) (1)
Gene therapy for the vulnerable atherosclerotic plaque (1996) (1)
5-fluorouracil induces vasoconstriction of vascular smooth muscle in vitro: Evidence that vasospasm is the basis for cardiovascular and cerebrovascular ischemic complications of 5-fluorouracil (1991) (1)
Use of computed tomography in the initial diagnosis and subsequent follow-up of cardiac neoplasms (1982) (1)
Gene Therapy and Local Drug Delivery (2000) (1)
Transesophageal echocardiographic guidance during percutaneous laser myoplasty for hypertrophic cardiomyopathy: Results of a canine trial (1990) (1)
1017-74 Length of Hospital Stay After Percutaneous Transluminal Coronary Angioplasty: Clinical and Angiographic Predictors (1995) (1)
404-5 Vascular endothelial growth factor (VEGF) plays a central role in the development of diabetic cardiomyopathy and gene transfer of VEGF improves heart failure in long-standing streptozotocin-induced diabetic rat (2004) (0)
Room 302, 10/18/2000 9: 00 AM - 10: 30 AM (PD) Perioperative Management of Gene Therapy for Inoperable Coronary Artery Disease: Results of a Phase 1 Clinical Trial A-258 (2000) (0)
803-2 Histological and Molecular Biological Characteristics of Restenotic Sapheneous Vein Grafts Post-Angioplasty (1995) (0)
Images in clinical medicine. Endovascular stents for iliac arterial disease. (1993) (0)
EXPERIMENTAL STUDIES Passivation of Metallic Stents After Arterial Gene Transfer of phVEGF 165 Inhibits Thrombus Formation and Intimal Thickening (2016) (0)
796-3 Treatment of Superficial Femoral Artery Occlusion by Percutaneous Revascularization of Ipsilateral Iliac Artery Stenosis (1995) (0)
A process for the regulation of angiogenesis (1997) (0)
Cardiology clinics: peripherAl vascular disease in the elderly edited by Michael H. Crawford and Donald J. Breslin W. B. Saunders company, Philadelphia (1991) 150 pages, illustrated, £19.00 ISSN: 0733–8651 (1992) (0)
KEY REFERENCES Cardiac Pathology (2005) (0)
The association of false-positive ST-T wave changes secondary to hyperventilation and mitral valve prolapse (1978) (0)
Diagnostic and therapeutic cardiac catheterization edited by Carl J. Pepine, James A. Hill, Charles R. Lambert Williams & Wilkins, Baltimore (1989) 612 pages, illustrated, $69.50 ISBN: 0-683-06851-2 (1990) (0)
Sickle erythrocytes inhibit endothelium-dependent relaxing factor (1991) (0)
Jeffrey Isner (2001) (0)
Low level laser energy delivered percutaneously in vivo reverses spasm induced by administration of intraarterial histamine to atherosclerotic microswine (1990) (0)
Patent Number : 45 Date of Patent : 5 , 652 , 225 Jul . 29 , 1997 (2017) (0)
Compositions et methodes modulant la vascularisation (1999) (0)
ARTERIAL GENE THERAPY. AUTHOR'S REPLY (1996) (0)
Percutaneous arterial gene transfer using pure DNA applied to a hydrogel-coated angioplasty balloon (1993) (0)
2.W12.2 Towards gene therapy for vascular disorders (1997) (0)
Laser-tissue interactions: vascular reactivity. (1993) (0)
Jeffrey Michael Isner, MD: a conversation with the editor. Interview by William Clifford Roberts. (1999) (0)
0965 HYPOXIA INDUCES VASCULAR ENDOTHELIAL GROWTH FACTOR IN CULTURED HUMAN ENDOTHELIAL CELLS (1996) (0)
Expression of 92 KDA Gelatinase in Human Atherosclerotic Lesions Following Recent Plaque Rupture (1995) (0)
Successful gene therapy following direct injection of naked DNA encoding secreted protein into skeletal muscle (1996) (0)
Intravascular ultrasound of renal arteries in patients undergoing percutaneous transluminal angioplasty: Feasibility, safety and initial findings, including 3 dimensional reconstruction of renal arteries (1991) (0)
903-15 Expression of 92 kDa Gelatinase in Primary Atherosclerotic vs Restenotic Coronary Lesions: Evidence for Mechanical Plaque Stabilization (1995) (0)
Common femoral artery percutaneous intervention: Feasibility, safety, and clinical outcomes (2003) (0)
Initial North American experience with inoue balloon for percutaneous mitral valvuloplasty (1990) (0)
Failure of Angiography to Dia Thermal Perforation Complic Laser Angioplasty in (1987) (0)
Progenitor Cells in Human Subjects Gene Transfer Augments Circulating Endothelial 165 Vascular Endothelial Growth Factor (2000) (0)
980-84 Restenosis of Stented Dialysis Conduits Caused by Stent Collapse, not Neointimal Proliferation (1995) (0)
Role of Percutaneous Revascularization (2005) (0)
Walking improvement questionnaire: a potential standardized instrument for evaluating functional improvement after peripheral angioplasty (1998) (0)
Sudden unexpected death and left ventricular mass: A necropsy analysis (1990) (0)
Vascular applications of human gene therapy (1995) (0)
Comment Excimer Laser Atherectomy The Greening of Sisyphus (2005) (0)
Percutaneous laser myoplasty for treatment of hypertrophic cardiomyopathy (1990) (0)
Popliteal artery ultrasound examination (PAUSE) (1996) (0)
Angiotensin Converting Enzyme Inhibition With Quinaprilate Stimulates Angiogenesis in a Rabbit Model of Hindlimb Ischemia (1998) (0)
Monoclonal immunolocalization of apolipoproteins b a i and e in human atherosclerotic plaque (1986) (0)
Meeting of the British Microcirculation Society. Editor: Barbara Ward (1999) (0)
Chlorotetracycline-induced fluorescence from calcilic plaque with UV laser excitation (1988) (0)
Abstracts - posterAngiotensin converting enzyme inhibition with quinaprilate stimulates angiogenesis in a rabbit model of hindlimb ischemia (1998) (0)
Model of Lower Limb Vascular Insufficiency (2007) (0)
Stem Cell Culture (2002) (0)
Excimer laser angioplasty in conjunction with intravascular ultrasonic imaging (1992) (0)
Gross, histologic, and ultrastructural features of cardiac involvement in alkaptonuria (1982) (0)
[Advances in percutaneous coronary revascularization]. (1993) (0)
Xenograft) With Postoperative Hemodynamk Evaluaf ion (2015) (0)
Long-term pathologic findings after in vivo placement of percutaneous balloon expandable tantalum stents (1990) (0)
1.E.1 New approaches to vascular and lipid disorders: From genes to therapy (1997) (0)
[Effects of continuous laser on arterial vasomotoricity in vitro]. (1989) (0)
Permanent pacemaker therapy in corrected transposition of the great vessels: Evaluation of site of lead placement in 39 patients (1982) (0)
1104-192 Heterologous transplantation of CD34+cells from patients with coronary ischemia leads to myocardial salvage and enhanced functional recovery in murine model of myocardial infarction (2004) (0)
Therapeutic Angiogenesis for the Treatment of Cardiovascular Disease (2002) (0)
The CNS-Bone Marrow Connection: Searching for the Hidden Treasures for Vascular Repair (2011) (0)
Interobserver variability inthepathologic interpretation ofendomyocardial biopsy results (1987) (0)
Arterial spasm : a thermal complication of continuous-wave but not pulsed laser angioplasty (1989) (0)
Time course of transforming growth factor-beta-1 expression in human arterial restenosis (1993) (0)
Right ventricular infarction. (1987) (0)
Qualitative assessment of peripheral vessels by intravascular ultrasound before and after interventions (1990) (0)
Atherosclerosis: Pathology of the Vasculature in Live Patients (1999) (0)
The worst cardiac disease. (1979) (0)
Letters totheEditor Letters totheEditor will bepublished, ifsuitable, asspace permits. Theyshould notexceed 500words (typed double-spaced) inlength andmaybesubject toediting orabridgment. AreRestenosis Cells Containing Nonmuscle Myosin Really Vascular Smooth Muscle Cells? (1992) (0)
Proteoglycans Biglycan and Decorin in the Extracellular Matrix of Atherosclerotic and Restenotic Human Coronary Arteries (2007) (0)
Assessement of restenosis vs primary lesions in patients with peripheral vascular disease using in situ hybridization and gene expression of two nonmuscle myosin isoforms (1991) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jeffrey M. Isner?

Jeffrey M. Isner is affiliated with the following schools:

Jeffrey M. Isner's Academic­Influence.com Rankings

Why Is Jeffrey M. Isner Influential?

Jeffrey M. Isner's Published Works

Published Works

What Schools Are Affiliated With Jeffrey M. Isner?

Jeffrey M. Isner's AcademicInfluence.com Rankings